Dan Suesskind - Israel Corp Independent Director
| ILCO Stock | ILA 88,800 800.00 0.91% |
Director
Mr. Dan S. Suesskind serves as Independent Director at Israel Corporation Ltd. since November 23, 2011. He is a member of the Compensation, Finance and Balance Sheets committees. His work experience includes the following roles Chief Financial Officer at Teva Pharmaceutical Industries Ltd. and Director at Migdal Insurance Company, Redhill Biopharma Ltd, Teva Pharmaceutical Industries Ltd., Ness Technologies Ltd. and Syneron Medical Ltd. He has held and holds Directorship at various additional companies. Mr. Suesskind holds a Bachelors degree in Economics and Political Science from The Hebrew University of Jerusalem and a MBA degree from University of Massachusetts, USA. Mr. Suesskind is a member of the Israeli Forum of Chief Financial Officers and was awarded the Life Time Achievement Award from this Forum in 2007. since 2011.
| Age | 75 |
| Tenure | 13 years |
| Professional Marks | MBA |
| Phone | 972 3 684 4500 |
| Web | https://www.israelcorp.com |
Israel Corp Management Efficiency
The company has return on total asset (ROA) of 0.1735 % which means that it generated a profit of $0.1735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.405 %, meaning that it generated $0.405 on every $100 dollars invested by stockholders. Israel Corp's management efficiency ratios could be used to measure how well Israel Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jean Halfon | Teva Pharmaceutical Industries | 62 | |
| Haim Samet | Bank Leumi Le Israel | 72 | |
| Ammon Dick | Bank Hapoalim | 62 | |
| Nurit Segal | Bank Leumi Le Israel | 72 | |
| Nir Zichlinskey | Bank Hapoalim | 49 | |
| Yigal Neeman | Elbit Systems | 73 | |
| Orly Guy | Bezeq Israeli Telecommunication | 56 | |
| Ami Barlev | Bezeq Israeli Telecommunication | 39 | |
| Ester Levanon | Bank Leumi Le Israel | 71 | |
| Ester Dominissini | Bank Leumi Le Israel | 67 | |
| Yitzhak Peterburg | Teva Pharmaceutical Industries | 65 | |
| Shlomo Rodav | Bezeq Israeli Telecommunication | 67 | |
| Amnon Dick | Bank Hapoalim | 63 | |
| Yoram BenZeev | Elbit Systems | 74 | |
| Noam Hanegbi | Bank Hapoalim | 61 | |
| Perry Nisen | Teva Pharmaceutical Industries | 63 | |
| Nechemia Peres | Teva Pharmaceutical Industries | 60 | |
| Edith Lusky | Bezeq Israeli Telecommunication | 66 | |
| Ehud Mezuman | Bezeq Israeli Telecommunication | 62 | |
| Dalia Rabin | Elbit Systems | 66 | |
| Ilan Biran | Bezeq Israeli Telecommunication | 70 | |
Management Performance
| Return On Equity | 0.41 | |||
| Return On Asset | 0.17 |
Israel Corp Leadership Team
Elected by the shareholders, the Israel Corp's board of directors comprises two types of representatives: Israel Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Israel. The board's role is to monitor Israel Corp's management team and ensure that shareholders' interests are well served. Israel Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Israel Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amnon Lion, Director | ||
| Johanan Locker, Director | ||
| Joshua Rosensweig, External Director | ||
| Avisar Paz, CEO | ||
| Yoav Doppelt, Chief Executive Officer | ||
| Yair Caspi, Director | ||
| Jacob Amidror, External & Independent Director | ||
| Maya Kaplan, Executive Vice President, General Counsel, Company Secretary | ||
| Zehavit Cohen, Director | ||
| Oded Degany, External Director | ||
| Ron Moskovitz, Director | ||
| Eran Sarig, Executive VP of Bus. Devel. and Strategy | ||
| Gideon Langholz, External Director | ||
| Maya AlschichKaplan, Gen VP | ||
| Natan Yalovsky, Acting CFO | ||
| Aviad Kaufman, Chairman of the Board | ||
| Dan Suesskind, Independent Director | ||
| Tali Michaud, Independent Director | ||
| Ovadia Eli, Chairman ORL | ||
| Idan Hizki, Sr Relations | ||
| Asher Grinbaum, COO Ltd | ||
| Shay Ohayon, Controller | ||
| Michael Bricker, Director | ||
| Ofer Alkalay, Internal Auditor | ||
| Sagi Kabla, Vice President - Finance |
Israel Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Israel Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.41 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 18.11 B | |||
| Shares Outstanding | 7.7 M | |||
| Shares Owned By Insiders | 50.33 % | |||
| Shares Owned By Institutions | 16.04 % | |||
| Price To Book | 1.30 X | |||
| Price To Sales | 0.96 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Israel Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Israel Stock analysis
When running Israel Corp's price analysis, check to measure Israel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Israel Corp is operating at the current time. Most of Israel Corp's value examination focuses on studying past and present price action to predict the probability of Israel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Israel Corp's price. Additionally, you may evaluate how the addition of Israel Corp to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |